" class="no-js "lang="en-US"> Financing Archives - Medtech Alert
Saturday, February 04, 2023

Sort by:


Top Post

NHS To Offer Licensed Cannabis-Based Medicine To Treat Rare Genetic Condition

The NHS will be able to prescribe cannabidiol (Cannabis) to patients with a rare, seizure-causing […]

ADARx Pharmaceuticals Raises $46 Million in Financing as Lead Product Enters the Clinic

ADARx Pharmaceuticals, a clinical-stage biotechnology company developing RNA-targeting therapeutics, has announced the close of a […]

InDevR Raises $9 Million in Series B Financing and Partners with bioMérieux

InDevR, a provider of best-in-class analytical technologies for vaccines and biotherapeutics, announced that it has […]

SoniVie Raises $60m in Round C Financing and Appoints New Board Members

SoniVie, a medical device company developing a proprietary solution to treat hypertension, announced today the […]

Amolyt Pharma Announces $138 Million Series C Financing

Amolyt Pharma, a global company specialized in developing therapeutic peptides for rare endocrine and related […]

Immune-Onc Therapeutics Announces Close of Series B Extension Financing, Bringing Total Round to $131 Million

Immune-Onc Therapeutics, a private, clinical-stage cancer immunotherapy company developing novel biotherapeutics targeting myeloid checkpoints has […]

HighTide Therapeutics Raises $107 Million in Series Financing to Advance Innovative Pipeline and Business Collaborations

HighTide Therapeutics, a globally integrated clinical-stage biopharmaceutical company developing novel multifunctional therapies for metabolic and […]

Onc.AI Raises $25 Million Series A Financing Co-Led by MassMutual and Action Potential Venture Capital

Onc.AI, a medical technology company developing a novel digital clinical management solution focused on immuno-oncology, […]

Actimed Therapeutics Closes Second Tranche of £10m Seed Financing

Actimed Therapeutics, a UK based clinical stage specialty pharmaceutical company focused on bringing innovation to […]

  1. Treadwell Therapeutics Announces the Appointment of Roger Sidhu, M.D., as Chief Medical Officer Read more
  2. Personalis and Moderna Sign New Agreement to Leverage NeXT Platform™ in Personalized mRNA Cancer Vaccine Clinical Trials Read more
  3. Trelleborg to Expand its BioPharmaceutical Manufacturing Footprint in Europe Read more
  4. Revive Therapeutics Enters into Research Collaboration Agreement with PharmaTher for Development of MDMA Transdermal Patch Read more
  5. Accenture Expands Strategy Capabilities in Life Sciences with the Acquisition of Bionest Read more